Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

rare disease

POPULAR ARTICLES

pharmaceutical investing

Novelion Therapeutics Reports First Quarter 2018 Financial Results

Shire: 1st Quarter Results

Shire: FDA APPROVES VONVENDI

LATEST ARTICLES

pharmaceutical investing

Ascendis Pharma Reports Full Year 2017 Financial Results

pharmaceutical investing

Strongbridge Biopharma Reports Full-Year 2017 Financial Results

pharmaceutical investing

Sarepta Therapeutics Announces Fourth Quarter 2017 and Full-Year 2017 Financial Results

Shire, Microsoft and EURORDIS form Global Commission

pharmaceutical investing

Agios Reports Fourth Quarter and Full Year 2017 Financial Results

Critical Outcome Technologies' CEO To Co-Chair Gene Forum

Aeglea BioTherapeutics Shares Patient Update for Phase 1/2 Clinical Trial

pharmaceutical investing

Resverlogix Gets Health Canada Approval for Apabetalone Trial

pharmaceutical investing

Actinium Obtains Orphan Drug Designation in Europe

Aldeyra Gets Orphan Drug Designation for ADX-102

Pharmaceutical Investing

pharmaceutical investing

Alexion To Lay Off Staff And Refocus Strategy

pharmaceutical investing

Catalyst Pharmaceuticals Supports Rare Disease Day® and Joins Global Movement to Raise Important Awareness for Rare Diseases

Latest News

1911 Gold Temporarily Suspends Operations at True North Complex due to Bissett Evacuation Order

Brunswick Exploration Completes Brokered Private Placement for Gross Proceeds of C$3.5 Million

Juggernaut Files for Final Approval of Oversubscribed Financing

Quimbaya Gold Inc. Announces Participation in THE Mining Investment Event, Quebec City, June 3-5, 2025

Charbone Hydrogen Announces Q1 2025 Financial Results